{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:37:48Z","timestamp":1774791468044,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12325-019-01140-z","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T18:02:59Z","timestamp":1573149779000},"page":"225-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the Long-Term Effectiveness of Cladribine vs. Placebo in the Relapsing-Remitting Multiple Sclerosis CLARITY Randomized Controlled Trial and CLARITY Extension Using Treatment Switching Adjustment Methods"],"prefix":"10.1007","volume":"37","author":[{"given":"Helen","family":"Bell Gorrod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas R.","family":"Latimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Damian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hettle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard T.","family":"Harty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schiffon L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"issue":"5","key":"1140_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/cam4.643","volume":"5","author":"NR Latimer","year":"2016","unstructured":"Latimer NR, Bell H, Abrams KR, Amonkar MM, Casey M. Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy. Cancer Med. 2016;5(5):806\u201315. \nhttps:\/\/doi.org\/10.1002\/cam4.643\n\n.","journal-title":"Cancer Med"},{"issue":"3","key":"1140_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1017\/S026646231600026X","volume":"32","author":"NR Latimer","year":"2016","unstructured":"Latimer NR, Henshall C, Siebert U, Bell H. Treatment switching: statistical and decision-making challenges and approaches. Int J Technol Assess Health Care. 2016;32(3):160\u20136. \nhttps:\/\/doi.org\/10.1017\/S026646231600026X\n\n.","journal-title":"Int J Technol Assess Health Care"},{"issue":"7","key":"1140_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1634\/theoncologist.2014-0429","volume":"20","author":"NR Latimer","year":"2015","unstructured":"Latimer NR, Abrams KR, Amonkar MM, Stapelkamp C, Swann RS. Adjusting for the confounding effects of treatment switching\u2014the BREAK-3 trial: dabrafenib versus dacarbazine. Oncologist. 2015;20(7):798\u2013805. \nhttps:\/\/doi.org\/10.1634\/theoncologist.2014-0429\n\n.","journal-title":"Oncologist."},{"key":"1140_CR4","volume-title":"NICE DSU technical support document 16: adjusting survival time estimates in the presence of treatment switching","author":"NR Latimer","year":"2014","unstructured":"Latimer NR, Abrams KR. NICE DSU technical support document 16: adjusting survival time estimates in the presence of treatment switching. Sheffield: Decision Support Unit; 2014."},{"issue":"4","key":"1140_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1586\/14737167.2015.1037835","volume":"15","author":"NR Latimer","year":"2015","unstructured":"Latimer NR. Treatment switching in oncology trials and the acceptability of adjustment methods. Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):561\u20134. \nhttps:\/\/doi.org\/10.1586\/14737167.2015.1037835\n\n.","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"issue":"8","key":"1140_CR6","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1080\/03610929108830654","volume":"20","author":"JM Robins","year":"1991","unstructured":"Robins JM, Tsiatis AA. Correcting for noncompliance in randomized trials using rank preserving structural failure time models. Commun Stat Theory Methods. 1991;20(8):2609\u201331.","journal-title":"Commun Stat Theory Methods"},{"issue":"17","key":"1140_CR7","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/sim.1219","volume":"21","author":"M Branson","year":"2002","unstructured":"Branson M, Whitehead J. Estimating a treatment effect in survival studies in which patients switch treatment. Stat Med. 2002;21(17):2449\u201363. \nhttps:\/\/doi.org\/10.1002\/sim.1219\n\n.","journal-title":"Stat Med"},{"issue":"3","key":"1140_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.0006-341X.2000.00779.x","volume":"56","author":"JM Robins","year":"2000","unstructured":"Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000;56(3):779\u201388.","journal-title":"Biometrics"},{"issue":"3","key":"1140_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/0272989X13520192","volume":"34","author":"NR Latimer","year":"2014","unstructured":"Latimer NR, Abrams KR, Lambert PC, Crowther MJ, Wailoo AJ, Morden JP, et al. Adjusting survival time estimates to account for treatment switching in randomized controlled trials\u2014an economic evaluation context: methods, limitations, and recommendations. Med Decis Mak. 2014;34(3):387\u2013402. \nhttps:\/\/doi.org\/10.1177\/0272989X13520192\n\n.","journal-title":"Med Decis Mak"},{"issue":"2","key":"1140_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0733-8619(05)70257-7","volume":"14","author":"BG Weinshenker","year":"1996","unstructured":"Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin. 1996;14(2):291\u2013308.","journal-title":"Neurol Clin"},{"issue":"2","key":"1140_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1212\/WNL.58.2.169","volume":"58","author":"DS Goodin","year":"2002","unstructured":"Goodin DS, Frohman EM, Garmany GP Jr, Halper J, Likosky WH, Lublin FD, et al. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002;58(2):169\u201378.","journal-title":"Neurology."},{"issue":"5","key":"1140_CR12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa0902533","volume":"362","author":"G Giovannoni","year":"2010","unstructured":"Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sorensen P, et al. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med. 2010;362(5):416\u201326. \nhttps:\/\/doi.org\/10.1056\/NEJMoa0902533\n\n.","journal-title":"N Engl J Med"},{"key":"1140_CR13","unstructured":"eMC. MAVENCLAD 10\u00a0mg tablets. 2017. \nhttps:\/\/www.medicines.org.uk\/emc\/medicine\/34044\n\n. Accessed 18 Dec 2017."},{"key":"1140_CR14","doi-asserted-by":"crossref","unstructured":"World Medical Association. WMA declaration of Helsinki\u2014ethical principles for medical research involving human subjects. 2017. \nhttps:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/\n\n. Accessed 14 Jul 2017.","DOI":"10.1515\/9783110208856.233"},{"issue":"2","key":"1140_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/105294199277860","volume":"6","author":"JR Dixon","year":"1999","unstructured":"Dixon JR. The international conference on harmonization good clinical practice guideline. Qual Assur. 1999;6(2):65\u201374.","journal-title":"Qual Assur"},{"issue":"2","key":"1140_CR16","first-page":"140","volume":"2","author":"IR White","year":"2002","unstructured":"White IR, Walker S, Babiker AG. strbee: randomization-based efficacy estimator. Strata J. 2002;2(2):140\u201350.","journal-title":"Strata J."},{"issue":"7","key":"1140_CR17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jval.2018.11.015","volume":"22","author":"H Bell Gorrod","year":"2019","unstructured":"Bell Gorrod H, Latimer NR, Damian D, Hettle R, Harty GT, Wong LS. Impact of non-randomised drop-out on treatment switching adjustment in the relapsing-remitting multiple sclerosis CLARITY trial and the CLARITY Extension study. Value Health. 2019;22(7):772\u20136.","journal-title":"Value Health."},{"issue":"10130","key":"1140_CR18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/s0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet (London, England). 2018;391(10130):1622\u201336. \nhttps:\/\/doi.org\/10.1016\/s0140-6736(18)30481-1\n\n.","journal-title":"Lancet (London, England)."},{"key":"1140_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cct.2014.12.011","volume":"41","author":"X Meng","year":"2015","unstructured":"Meng X, Chin PS, Hashmonay R, Zahur Islam M, Cutter G. Effect of switching from intramuscular interferon beta-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS. Contemp Clin Trials. 2015;41:69\u201374. \nhttps:\/\/doi.org\/10.1016\/j.cct.2014.12.011\n\n.","journal-title":"Contemp Clin Trials."},{"issue":"19","key":"1140_CR20","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1002\/(SICI)1097-0258(19991015)18:19<2617::AID-SIM187>3.0.CO;2-E","volume":"18","author":"IR White","year":"1999","unstructured":"White IR, Babiker AG, Walker S, Darbyshire JH. Randomization-based methods for correcting for treatment changes: examples from the Concorde trial. Stat Med. 1999;18(19):2617\u201334.","journal-title":"Stat Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01140-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-01140-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01140-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:31:08Z","timestamp":1604622668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-01140-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01140-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}